๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

P.5.a.005 An open label study of mirtazapine in the treatment of depression with Alzheimer's disease

โœ Scribed by W. Hahm

Book ID
118597492
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
44 KB
Volume
20
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

An open-label study of escitalopram (Lex
An open-label study of escitalopram (Lexaproยฎ) for the treatment of โ€˜Depression of Alzheimer's diseaseโ€™ (dAD)
โœ V. Rao; J. R. Spiro; P. B. Rosenberg; H. B. Lee; A. Rosenblatt; C. G. Lyketsos ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 43 KB ๐Ÿ‘ 2 views

## Abstract ## Background Depression is a frequent neuropsychiatric complication of Alzheimer's Disease. ## Methods This study investigated the safety and effectiveness of escitalopram (LEXAPRO) for depression in AD (dAD) as defined by the NIMH consensus criteria in an 8โ€week, openโ€label treatme